Add Yahoo as a preferred source to see more of our stories on Google. A vial and syringe are seen in front of Merck logo in this illustration taken March 26, 2025. REUTERS/Dado Ruvic/Illustration Jan ...

A biopharmaceutical company collaborating with Hawai'i scientists on an Ebola vaccine announced encouraging news about its vaccine today. Tests on the vaccine, still in development, have shown it is ...

Viruses are masters at invading cells thanks to specialized proteins that coat their surfaces. When scientists design ...

The World Health Organization says millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines will start being tested in March. Still, the ...

Does the blood of Ebola virus disease survivors contain antibodies and immune cells that could help doctors fight Ebola infections in other people? An all-star team of researchers will begin answering ...

Viruses are masters at invading our cells thanks to specialized proteins that coat their surfaces. When scientists design ...

An experimental Ebola vaccine will be tested on humans for the first time next week in a collaboration between the U.S. government and pharmaceutical company GlaxoSmithKline. There are other drugs on ...

An Ebola-infected American doctor receiving treatment in Nebraska has shown some improvement but is still “very sick,” his wife said in a statement. Dr. Rick Sacra, 51, a Boston-area obstetrician, ...

The World Health Organization (WHO) on Tuesday said it had prequalified an Ebola vaccine for the first time, hailing a "critical step" towards its licensing, access and roll-out in countries most at ...

Even if Ebola has receded from the headlines, a consortium led by a University of Minnesota infectious disease expert is urging world health officials to accelerate the creation of a vaccine against ...

(Reuters) - Merck & Co said on Friday it expects to make licensed doses of its recently approved Ebola vaccine available in the third quarter of 2020 and price the single-dose injection at the lowest ...